Leif RW Erhardt (Former)
11 – 20 of 59
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2007
-
Mark
Comprehensive cardiovascular risk management--what does it mean in practice?
(
- Contribution to journal › Scientific review
-
Mark
Rationale for multiple risk intervention: the need to move from theory to practice.
(
- Contribution to journal › Article
- 2006
-
Mark
A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure - A report from the Carvedilol or Metoprolol European Trial (COMET)
(
- Contribution to journal › Article
-
Mark
The evolution of European guidelines: Changing the management of cholesterol levels.
(
- Contribution to journal › Scientific review
-
Mark
Knowing your risk factors for coronary heart disease improves adherence to advice on lifestyle changes and medication
(
- Contribution to journal › Article
- 2005
-
Mark
An emerging role for calcium sensitisation in the treatment of heart failure.
(
- Contribution to journal › Scientific review
-
Mark
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice
(
- Contribution to journal › Article
-
Mark
Hypertensive smokers have a worse cardiovascular risk profile than non-smokers in spite of treatment - A national study in Sweden
(
- Contribution to journal › Article
-
Mark
Factors associated with development of stroke long-term after myocardial infarction: experiences from the LoWASA trial
(
- Contribution to journal › Article
-
Mark
A review of the current evidence for the use of angiotensin-receptor blockers in chronic heart failure.
(
- Contribution to journal › Scientific review